Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

5(62.5%)

Phase 2

1(12.5%)

Phase 4

1(12.5%)

Phase 3

1(12.5%)

8Total

N/A(5)

Phase 2(1)

Phase 4(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07430696Phase 2Not Yet Recruiting

INVESTIGATION OF THE ANTI-NEOPLASTIC EFFECT OF TRISHUL (AYURVEDIC AGENT) ON TUMOUR REGRESSION OF RECTAL CANCER- A PILOT STUDY

Role: lead

NCT02341651Not ApplicableCompleted

Control of Blood Pressure and Risk Attenuation-rural Bangladesh, Pakistan, Sri Lanka, Feasibility Study

Role: collaborator

NCT02387385Not ApplicableCompleted

Hypothermia for Encephalopathy in Low and Middle-Income Countries Trial

Role: collaborator

NCT02657746Not ApplicableUnknown

Primary Care Strategies to Reduce High Blood Pressure: A Cluster Randomized Trial in Rural Bangladesh, Pakistan and Sri Lanka

Role: collaborator

NCT01146496Not ApplicableCompleted

A Community Trial to Determine Whether 'Safe Storage' Reduces Pesticide Self-poisoning in Rural Asia

Role: collaborator

NCT01174381Not ApplicableCompleted

The Use of a Community-based Organization to Change Lifestyle Characteristics Related to Non Communicable Diseases

Role: lead

NCT01350271Phase 3Completed

Comparative Efficacy of Different Mebendazole Polymorphs in the Treatment of Soil-transmitted Helminth Infections

Role: lead

NCT00270777Phase 4Completed

Improving Safety of Antivenom in People Bitten by Snakes

Role: lead

All 8 trials loaded